Medpage Today on MSN17h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Medscape3d
The Role of Kidney in Glucose Homeostasis — SGLT2 Inhibitors, a New Approach in Diabetes Treatment
[1] The purpose of this review paper is to analyze the role of the kidney in glucose homeostasis, emphasizing in SGLT2 inhibition ... Urinary glucose excretion (g/24 h):/DP100 mg: 69.9/DP20 ...
EurekAlert!1d
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
The Lancet17h
Sodium–glucose co-transporter inhibitors—who would have guessed?
Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
Nature1d
Nephrology articles from across Nature Portfolio
The late diagnosis of chronic kidney disease (CKD) is a global problem that limits the opportunity to initiate disease-modifying therapies. Artificial intelligence approaches using imaging or ...
Daily6d
Empagliflozin Reduces CI-AKI Risk in PCI Patients by Improving Renal Function: Study Reveals
The study, published in Scientific Reports, suggests that this sodium-glucose cotransporter-2 (SGLT2) inhibitor may play a renoprotective role, particularly in middle-aged and elderly patients and ...
GP magazine3d
ACE inhibitors and renal artery stenosis
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Johns Hopkins Medicine2d
Kidney Scan
What is a kidney scan? A kidney scan is an imaging test that looks at your kidneys. Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a ...